Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can an elliptical trainer help MS patients walk better?

NCT ID NCT06583967

Symptom relief Sponsor: Soroka University Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how aerobic exercise on an elliptical trainer or a treadmill affects walking, balance, and stability in people with moderate multiple sclerosis. Thirty adults with MS completed the exercise programs. The goal was to see which machine might improve gait and walking abilities more.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Jun 2024

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 55 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients signed Informed Consent Form 2. At least 6 months post MS diagnosis 3. 25-55 years old adults 4. EDSS 3.0-6.5 5. Standing stability - for at least 30 seconds 6. 6MWT - minimal distance to be measured as 210 meters 7. No physical routinely training e.g. walking, elliptical or cycling within 3 months prior screening visit. Exclusion Criteria: 1. Active Heart Disease 2. Lungs and/or respiratory system diseases 3. Metabolic Disease 4. Any other medical condition(s) which might impact the patient's participant in the study, as per PI medical judgement 5. Major medical treatment change (as per PI medical judgement) up to 12 weeks prior ICF signature by the patient.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Multiple sclerosis (MS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Activity multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Multiple sclerosis (MS)

Contacts and locations

Locations

  • Israel ParaSport Center

    Ramat Gan, Israel, 52535, Israel

  • Soroka Medical Center

    Beersheba, Israel, 8410101, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.